Eduardo Bruera

Author PubWeight™ 271.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011 7.78
2 Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol 2013 5.07
3 Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain 2006 4.96
4 Availability and integration of palliative care at US cancer centers. JAMA 2010 4.51
5 Palliative cancer care a decade later: accomplishments, the need, next steps -- from the American Society of Clinical Oncology. J Clin Oncol 2009 3.36
6 Supportive versus palliative care: what's in a name?: a survey of medical oncologists and midlevel providers at a comprehensive cancer center. Cancer 2009 2.58
7 Ensuring quality cancer care: a follow-up review of the Institute of Medicine's 10 recommendations for improving the quality of cancer care in America. Cancer 2011 2.15
8 Dehydration in cancer patients: to treat or not to treat. J Support Oncol 2004 2.15
9 The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia. J Palliat Med 2013 2.00
10 Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer. Cancer 2010 1.97
11 Delirium in advanced cancer patients. Palliat Med 2004 1.92
12 Interval between first palliative care consult and death in patients diagnosed with advanced cancer at a comprehensive cancer center. J Palliat Med 2008 1.76
13 Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene. Pain 2006 1.72
14 Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine 2004 1.70
15 Interval between palliative care referral and death among patients treated at a comprehensive cancer center. J Palliat Med 2005 1.67
16 Patient-physician communication about code status preferences: a randomized controlled trial. Cancer 2013 1.66
17 NCCN clinical practice guidelines in oncology: palliative care. J Natl Compr Canc Netw 2009 1.66
18 Association between a name change from palliative to supportive care and the timing of patient referrals at a comprehensive cancer center. Oncologist 2011 1.61
19 Effects of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double-blind placebo-controlled trial. J Clin Oncol 2013 1.59
20 An international multicentre validation study of a pain classification system for cancer patients. Eur J Cancer 2010 1.59
21 The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study. J Palliat Med 2010 1.57
22 Palliative management of fatigue at the close of life: "it feels like my body is just worn out". JAMA 2007 1.57
23 Bedside clinical signs associated with impending death in patients with advanced cancer: preliminary findings of a prospective, longitudinal cohort study. Cancer 2015 1.56
24 Palliative care inpatient service in a comprehensive cancer center: clinical and financial outcomes. J Clin Oncol 2004 1.55
25 Inpatient rehabilitation improved functional status in asthenic patients with solid and hematologic malignancies. Am J Phys Med Rehabil 2011 1.54
26 Impact of timing and setting of palliative care referral on quality of end-of-life care in cancer patients. Cancer 2014 1.49
27 Discharge outcomes and survival of patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center. J Palliat Med 2010 1.48
28 Cancer patients' perceptions regarding the value of the physical examination: a survey study. Cancer 2014 1.44
29 The use of very-low-dose methadone and haloperidol for pain control in the hospital setting: a preliminary report. J Palliat Med 2014 1.39
30 Impact of a palliative care consultation team on cancer-related symptoms in advanced cancer patients referred to an outpatient supportive care clinic. J Pain Symptom Manage 2010 1.37
31 Access to palliative care among patients treated at a comprehensive cancer center. Oncologist 2012 1.34
32 Characteristics, findings, and outcomes of palliative care inpatient consultations at a comprehensive cancer center. J Palliat Med 2007 1.32
33 Quantity, design, and scope of the palliative oncology literature. Oncologist 2011 1.32
34 The lack of standard definitions in the supportive and palliative oncology literature. J Pain Symptom Manage 2011 1.30
35 Pain and emotional distress in leukemia patients at diagnosis. Leuk Res 2009 1.26
36 Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids. Cancer 2004 1.25
37 The accuracy of probabilistic versus temporal clinician prediction of survival for patients with advanced cancer: a preliminary report. Oncologist 2011 1.24
38 A systematic review of randomized trials on the effectiveness of opioids for cancer pain. Pain Physician 2012 1.24
39 Spirituality, religiosity, and spiritual pain in advanced cancer patients. J Pain Symptom Manage 2011 1.23
40 Targeted agent use in cancer patients at the end of life. J Pain Symptom Manage 2012 1.22
41 Symptom control in palliative care--Part II: cachexia/anorexia and fatigue. J Palliat Med 2006 1.22
42 Potent analgesics are more expensive for patients in developing countries: a comparative study. J Pain Palliat Care Pharmacother 2004 1.22
43 Assessing hope at the end of life: validation of an experience of hope scale in advanced cancer patients. Palliat Support Care 2004 1.20
44 Consensus guideline on parenteral methadone use in pain and palliative care. Palliat Support Care 2008 1.20
45 Can this patient be discharged home? Factors associated with at-home death among patients with cancer. J Clin Oncol 2011 1.20
46 Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Lancet Oncol 2008 1.19
47 Antineoplastic therapy use in patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center: a simultaneous care model. Cancer 2010 1.19
48 Characteristics and correlates of dyspnea in patients with advanced cancer. J Palliat Med 2009 1.18
49 A comprehensive study of psychometric properties of the Edmonton Symptom Assessment System (ESAS) in Spanish advanced cancer patients. Eur J Cancer 2011 1.17
50 Comparison of symptom burden among patients referred to palliative care with hematologic malignancies versus those with solid tumors. J Palliat Med 2008 1.17
51 Alcoholism screening in patients with advanced cancer: impact on symptom burden and opioid use. J Palliat Med 2008 1.15
52 Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study. Cancer 2014 1.14
53 Predictors of access to palliative care services among patients who died at a Comprehensive Cancer Center. J Palliat Med 2007 1.14
54 NOPPAIN: a nursing assistant-administered pain assessment instrument for use in dementia. Dement Geriatr Cogn Disord 2004 1.14
55 Symptom distress, interventions, and outcomes of intensive care unit cancer patients referred to a palliative care consult team. Cancer 2009 1.13
56 Symptom control in palliative care--Part III: dyspnea and delirium. J Palliat Med 2006 1.13
57 Quality of life and survival prediction in terminal cancer patients: a multicenter study. Cancer 2004 1.12
58 Switching from methadone to a different opioid: what is the equianalgesic dose ratio? J Palliat Med 2008 1.12
59 Opioid switching: a systematic and critical review. Cancer Treat Rev 2006 1.10
60 Dyspnea in hospitalized advanced cancer patients: subjective and physiologic correlates. J Palliat Med 2013 1.10
61 The impact of palliative care consultation on symptom assessment, communication needs, and palliative interventions in pediatric patients with cancer. J Palliat Med 2009 1.09
62 The assessment and management of delirium in cancer patients. Oncologist 2009 1.08
63 Botulinum toxin injection and phenol nerve block for reduction of end-of-life pain. J Palliat Med 2013 1.08
64 Dual opioid therapy using methadone as a coanalgesic. Expert Opin Drug Saf 2014 1.08
65 Symptom control in palliative care--Part I: oncology as a paradigmatic example. J Palliat Med 2006 1.08
66 Undocumented alcoholism and its correlation with tobacco and illegal drug use in advanced cancer patients. Cancer 2011 1.07
67 The Edmonton Symptom Assessment System as a screening tool for depression and anxiety. J Palliat Med 2006 1.06
68 Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Support Care Cancer 2008 1.06
69 Concepts and definitions for "supportive care," "best supportive care," "palliative care," and "hospice care" in the published literature, dictionaries, and textbooks. Support Care Cancer 2012 1.06
70 Cytokine genes and pain severity in lung cancer: exploring the influence of TNF-alpha-308 G/A IL6-174G/C and IL8-251T/A. Cancer Epidemiol Biomarkers Prev 2007 1.05
71 Attitudes of terminally ill cancer patients about euthanasia and assisted suicide: predominance of psychosocial determinants and beliefs over symptom distress and subsequent survival. J Clin Oncol 2002 1.05
72 Parents dying of cancer and their children. Palliat Support Care 2004 1.04
73 Racial disparities in the use of hospice services according to geographic residence and socioeconomic status in an elderly cohort with nonsmall cell lung cancer. Cancer 2010 1.03
74 Genetic and nongenetic covariates of pain severity in patients with adenocarcinoma of the pancreas: assessing the influence of cytokine genes. J Pain Symptom Manage 2009 1.02
75 Clinical response to an outpatient palliative care consultation in patients with advanced cancer and cancer pain. J Pain Symptom Manage 2012 1.02
76 Impact of a half-day multidisciplinary symptom control and palliative care outpatient clinic in a comprehensive cancer center on recommendations, symptom intensity, and patient satisfaction: a retrospective descriptive study. J Pain Symptom Manage 2004 1.02
77 The role of thalidomide and placebo for the treatment of cancer-related anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study. J Palliat Med 2012 1.02
78 Integrative medicine consultation service in a comprehensive cancer center: findings and outcomes. Integr Cancer Ther 2010 1.02
79 The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: a pilot study. Cancer 2006 1.00
80 Attrition rates, reasons, and predictive factors in supportive care and palliative oncology clinical trials. Cancer 2012 0.99
81 Routine symptom assessment: good for practice and good for business. Support Care Cancer 2008 0.97
82 Predictors of inpatient mortality in an acute palliative care unit at a comprehensive cancer center. Support Care Cancer 2009 0.97
83 Use of palliative sedation for intractable symptoms in the palliative care unit of a comprehensive cancer center. Support Care Cancer 2008 0.97
84 Comfort in the last 2 weeks of life: relationship to accessing palliative care services. Support Care Cancer 2008 0.97
85 The frequency and correlates of spiritual distress among patients with advanced cancer admitted to an acute palliative care unit. Am J Hosp Palliat Care 2010 0.97
86 Association between fatigue and other cancer-related symptoms in patients with advanced cancer. Support Care Cancer 2008 0.97
87 At-home palliative sedation for end-of-life cancer patients. Palliat Med 2010 0.96
88 Validation of the Edmonton Symptom Assessment System in Korean patients with cancer. J Pain Symptom Manage 2013 0.96
89 Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study. J Pain Symptom Manage 2012 0.96
90 Phase angle for prognostication of survival in patients with advanced cancer: preliminary findings. Cancer 2014 0.96
91 Palliative pain management: when both pain and suffering hurt. J Palliat Care 2005 0.96
92 The influence of tumor necrosis factor-alpha -308 G/A and IL-6 -174 G/C on pain and analgesia response in lung cancer patients receiving supportive care. Cancer Epidemiol Biomarkers Prev 2008 0.96
93 Characteristics of patients who refuse do-not-resuscitate orders upon admission to an acute palliative care unit in a comprehensive cancer center. Cancer 2010 0.96
94 Palliative management of malignant bowel obstruction. Int J Gynecol Cancer 2002 0.95
95 Role of inflammation gene polymorphisms on pain severity in lung cancer patients. Cancer Epidemiol Biomarkers Prev 2009 0.95
96 Impact of a palliative care service on in-hospital mortality in a comprehensive cancer center. J Palliat Med 2006 0.95
97 A conceptual model of pain assessment for noncommunicative persons with dementia. Gerontologist 2004 0.95
98 The association between autonomic dysfunction and survival in male patients with advanced cancer: a preliminary report. J Pain Symptom Manage 2010 0.94
99 Opioid withdrawal syndrome after treatment with low-dose extended-release oxycodone and naloxone in a gastric cancer patient with portal vein thrombosis. J Pain Symptom Manage 2013 0.94
100 Clinical outcomes and contributors to weight loss in a cancer cachexia clinic. J Palliat Med 2011 0.94
101 Achievement of personalized pain goal in cancer patients referred to a supportive care clinic at a comprehensive cancer center. Cancer 2011 0.94
102 Clinical findings of a palliative care consultation team at a comprehensive cancer center. J Palliat Med 2008 0.94
103 The impact of an outpatient palliative care consultation on symptom burden in advanced prostate cancer patients. J Palliat Med 2011 0.94
104 Preliminary report: vitamin D deficiency in advanced cancer patients with symptoms of fatigue or anorexia. Oncologist 2011 0.94
105 Is there a role for hydration at the end of life? Curr Opin Support Palliat Care 2009 0.93
106 Complications of a gastrostomy tube used for decompression of an inoperable bowel obstruction in a patient with advanced cancer. J Pain Symptom Manage 2009 0.93
107 Subcutaneous olanzapine for hyperactive or mixed delirium in patients with advanced cancer: a preliminary study. J Pain Symptom Manage 2010 0.92
108 Association between self-reported sleep disturbance and other symptoms in patients with advanced cancer. J Pain Symptom Manage 2011 0.92
109 The relationship between body composition and response to neoadjuvant chemotherapy in women with operable breast cancer. Oncologist 2012 0.92
110 Factors associated with the severity and improvement of fatigue in patients with advanced cancer presenting to an outpatient palliative care clinic. BMC Palliat Care 2012 0.92
111 Minimal clinically important differences in the edmonton symptom assessment system: the anchor is key. J Pain Symptom Manage 2013 0.92
112 Medical oncologists' perception of palliative care programs and the impact of name change to supportive care on communication with patients during the referral process. A qualitative study. Palliat Support Care 2013 0.92
113 Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy. J Pain Symptom Manage 2003 0.92
114 Music-based interventions in palliative cancer care: a review of quantitative studies and neurobiological literature. Support Care Cancer 2013 0.91
115 The impact of the palliative care mobile team on symptom assessment and medication profiles in patients admitted to a comprehensive cancer center. Support Care Cancer 2006 0.91
116 To hydrate or not to hydrate: how should it be? J Clin Oncol 2003 0.91
117 Prevalence of symptom control and palliative care abstracts presented at the Annual Meeting of the American Society for Therapeutic Radiology and Oncology. Int J Radiat Oncol Biol Phys 2002 0.91
118 Predictors of long-term opioid treatment among patients who receive chemoradiation for head and neck cancer. Oncologist 2013 0.91
119 Advance directives and do-not-resuscitate orders in patients with cancer with metastatic spinal cord compression: advanced care planning implications. J Palliat Med 2010 0.90
120 The association between in-patient death, utilization of hospital resources and availability of palliative home care for cancer patients. Palliat Med 2012 0.90
121 Intermittent subcutaneous opioids for the management of cancer pain. J Palliat Med 2008 0.90
122 Single- vs. multiple-item instruments in the assessment of quality of life in patients with advanced cancer. J Pain Symptom Manage 2010 0.90
123 Associations among hypogonadism, C-reactive protein, symptom burden, and survival in male cancer patients with cachexia: a preliminary report. J Pain Symptom Manage 2010 0.90
124 Association between serum cortisol and testosterone levels, opioid therapy, and symptom distress in patients with advanced cancer. J Pain Symptom Manage 2011 0.90
125 Clinical characteristics of cancer patients referred early to supportive and palliative care. J Palliat Med 2013 0.89
126 Palliative care in developing countries: what are the important issues? Palliat Med 2007 0.89
127 Prognostic factors for survival in metastatic spinal cord compression: a retrospective study in a rehabilitation setting. Am J Phys Med Rehabil 2003 0.89
128 Quality of the supportive and palliative oncology literature: a focused analysis on randomized controlled trials. Support Care Cancer 2011 0.89
129 Assessment of palliative care cancer patients' most important concerns. Support Care Cancer 2010 0.89
130 Clinically important improvement in the intensity of fatigue in patients with advanced cancer. J Palliat Med 2007 0.88
131 Frequency and predictors of patient deviation from prescribed opioids and barriers to opioid pain management in patients with advanced cancer. J Pain Symptom Manage 2012 0.88
132 Palliative care units: the best option for the most distressed. Arch Intern Med 2011 0.88
133 Timing of palliative care referral and symptom burden in phase 1 cancer patients: a retrospective cohort study. Cancer 2010 0.88
134 Bowel and bladder continence, wound healing, and functional outcomes in patients who underwent sacrectomy. J Neurosurg Spine 2005 0.88
135 Corticosteroid rotation to alleviate dexamethasone-induced hiccup: a case series at a single institution. J Pain Symptom Manage 2011 0.88
136 Impact of physician sitting versus standing during inpatient oncology consultations: patients' preference and perception of compassion and duration. A randomized controlled trial. J Pain Symptom Manage 2005 0.88
137 Risk stratification of opioid misuse among patients with cancer pain using the SOAPP-SF. Pain Med 2013 0.88
138 Methadone initiation and rotation in the outpatient setting for patients with cancer pain. Cancer 2010 0.88
139 International Association for Hospice and Palliative Care (IAHPC) List of Essential Practices in Palliative Care. J Pain Palliat Care Pharmacother 2012 0.88
140 Changes in symptom intensity among cancer patients receiving outpatient palliative care. J Pain Symptom Manage 2013 0.88
141 High-flow oxygen and bilevel positive airway pressure for persistent dyspnea in patients with advanced cancer: a phase II randomized trial. J Pain Symptom Manage 2013 0.87
142 Neuroleptic dose in the management of delirium in patients with advanced cancer. J Pain Symptom Manage 2010 0.87
143 Delirium in advanced cancer leading to distress in patients and family caregivers. J Palliat Care 2009 0.87
144 The meaning of parenteral hydration to family caregivers and patients with advanced cancer receiving hospice care. J Pain Symptom Manage 2012 0.87
145 The frequency of missed delirium in patients referred to palliative care in a comprehensive cancer center. Support Care Cancer 2015 0.86
146 Palliative radiotherapy for patients with bone metastases: survey of primary care physicians. Radiother Oncol 2003 0.86
147 Global framework for noncommunicable diseases: how can we monitor palliative care? J Palliat Med 2012 0.86
148 Early referral to supportive care specialists for symptom burden in lung cancer patients: a comparison of non-Hispanic whites, Hispanics, and non-Hispanic blacks. Cancer 2011 0.86
149 Indicators of surgery and survival in oncology inpatients requiring surgical evaluation for palliation. Support Care Cancer 2008 0.86
150 Association between megestrol acetate treatment and symptomatic adrenal insufficiency with hypogonadism in male patients with cancer. Cancer 2007 0.86
151 Incidence of and risk factors for transferring cancer patients from rehabilitation to acute care units. Am J Phys Med Rehabil 2008 0.86
152 Challenge of managing cancer-related fatigue. J Clin Oncol 2010 0.86
153 Reporting of funding sources and conflict of interest in the supportive and palliative oncology literature. J Pain Symptom Manage 2012 0.85
154 Methadone-induced respiratory depression in a patient with a history of alcoholism. J Palliat Med 2005 0.85
155 Sensory and affective dimensions of advanced cancer pain. Psychooncology 2002 0.85
156 Challenges associated with spinal opioid therapy for pain in patients with advanced cancer: a report of three cases. J Pain Symptom Manage 2010 0.84
157 Predictors of high score patient-reported barriers to controlling cancer pain: a preliminary report. Support Care Cancer 2012 0.84
158 Neuroleptic prescription pattern for delirium in patients with advanced cancer. J Palliat Care 2011 0.84
159 Spinal analgesia: where is the evidence? Support Care Cancer 2010 0.84
160 The cachexia clinic: from staging to managing nutritional and functional problems in advanced cancer patients. Crit Rev Oncog 2012 0.84
161 Somatic symptoms in patients with chronic non-cancer-related and cancer-related pain. J Pain Symptom Manage 2005 0.84
162 Changes in symptoms and inpatient mortality: a study in advanced cancer patients admitted to an acute palliative care unit in a comprehensive cancer center. J Palliat Med 2011 0.84
163 Assessing cancer pain. Curr Pain Headache Rep 2012 0.84
164 Association between hypogonadism, symptom burden, and survival in male patients with advanced cancer. Cancer 2014 0.84
165 Factors associated with response to methylphenidate in advanced cancer patients. Oncologist 2011 0.84
166 Evaluation of the memorial delirium assessment scale (MDAS) for the screening of delirium by means of simulated cases by palliative care health professionals. Support Care Cancer 2007 0.84
167 Oral methadone for cancer pain: no indication of Q-T interval prolongation or torsades de pointes. J Pain Symptom Manage 2004 0.84
168 Prescribing patterns and purchasing costs of long-acting opioids over nine years at an academic oncology hospital. Am J Health Syst Pharm 2007 0.83
169 Frequency of depression among oncology outpatients and association with other symptoms. Support Care Cancer 2012 0.83
170 Characteristics of family conferences in a palliative care unit at a comprehensive cancer center. J Palliat Med 2008 0.83
171 Clinical, sociodemographic, and local system factors associated with a hospital death among cancer patients. Support Care Cancer 2005 0.83
172 Association between body image dissatisfaction and weight loss among patients with advanced cancer and their caregivers: a preliminary report. J Pain Symptom Manage 2012 0.83
173 A successful palliative care intervention for cancer pain refractory to intrathecal analgesia. J Pain Symptom Manage 2012 0.82
174 Spirituality, religiosity, and spiritual pain among caregivers of patients with advanced cancer. Am J Hosp Palliat Care 2012 0.82
175 Frequency, outcome, and predictors of success within 6 weeks of an opioid rotation among outpatients with cancer receiving strong opioids. Oncologist 2012 0.82
176 The International Association for Hospice and Palliative Care: international activities and future initiatives. J Pain Palliat Care Pharmacother 2003 0.82
177 Association between patient-reported symptoms and nurses' clinical impressions in cancer patients admitted to an acute palliative care unit. J Palliat Med 2012 0.82
178 Practical model for prognostication in advanced cancer patients: is less more? J Clin Oncol 2008 0.82
179 Supportive and palliative care: a poorly understood science for the perioperative clinician. Best Pract Res Clin Anaesthesiol 2013 0.82
180 Self-reported constipation in patients with advanced cancer: a preliminary report. J Pain Symptom Manage 2012 0.81
181 From roots to flowers: challenges of developing a sustainable palliative care program. J Palliat Care 2003 0.81
182 Association between supportive care interventions and patient self-reported depression among advanced cancer outpatients. Support Care Cancer 2013 0.81
183 Role of corticosteroids for fatigue in advanced incurable cancer: is it a 'wonder drug' or 'deal with the devil'. Curr Opin Support Palliat Care 2014 0.81
184 The effect of age on opioid switching to methadone: a systematic review. J Palliat Med 2012 0.81
185 Characterizing postoperative paralytic ileus as evidence for future research and clinical practice. Gastroenterol Nurs 2008 0.81
186 The association between anemia and fatigue in patients with advanced cancer receiving palliative care. J Palliat Med 2005 0.81
187 Return to primary service among bone marrow transplant rehabilitation inpatients: an index for predicting outcomes. Arch Phys Med Rehabil 2012 0.81
188 Errors in symptom intensity self-assessment by patients receiving outpatient palliative care. J Palliat Med 2006 0.81
189 Management of pain in the older person with cancer. Oncology (Williston Park) 2008 0.81
190 New opioids: expensive distractions or important additions to practice? J Palliat Med 2010 0.81
191 Experience of barriers to pain management in patients receiving outpatient palliative care. J Palliat Med 2013 0.81
192 The effects of a brief relaxation program on symptom distress and heart rate variability in cancer patients. PM R 2010 0.80
193 Unrelieved pain and suffering in patients with advanced cancer. Am J Hosp Palliat Care 2011 0.80
194 Evaluation and pharmacologic management of symptoms in cancer patients undergoing acute rehabilitation in a comprehensive cancer center. Arch Phys Med Rehabil 2007 0.80
195 Palliative care for delirium in patients in the last weeks of life: the final frontier. J Palliat Care 2014 0.80
196 Decisional control preferences of Hispanic patients with advanced cancer from the United States and Latin America. J Pain Symptom Manage 2012 0.80
197 Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma: results of a randomized clinical trial. Cancer 2011 0.80
198 Practice patterns and perceptions about parenteral hydration in the last weeks of life: a survey of palliative care physicians in Latin America. J Pain Symptom Manage 2011 0.80
199 Palliative sedation: when and how? J Clin Oncol 2012 0.80
200 Delirium with severe symptom expression related to hypercalcemia in a patient with advanced cancer: an interdisciplinary approach to treatment. J Pain Symptom Manage 2008 0.80
201 A month in an acute palliative care unit: clinical interventions and financial outcomes. Am J Hosp Palliat Care 2011 0.80
202 Predictors of response to palliative care intervention for chronic nausea in advanced cancer outpatients. Support Care Cancer 2013 0.79
203 Is there a role for parenteral nutrition or hydration at the end of life? Curr Opin Support Palliat Care 2012 0.79
204 A prospective study of family conferences: effects of patient presence on emotional expression and end-of-life discussions. J Pain Symptom Manage 2013 0.79
205 A phase III randomized, double-blind, placebo-controlled study evaluating dextromethorphan plus slow-release morphine for chronic cancer pain relief in terminally ill patients. J Pain Symptom Manage 2007 0.79
206 Treatment of dexamethasone-induced hiccup in chemotherapy patients by methylprednisolone rotation. Oncologist 2013 0.79
207 Screening for body image dissatisfaction in patients with advanced cancer: a pilot study. J Palliat Med 2014 0.79
208 Characteristics of advanced cancer patients with cancer-related fatigue enrolled in clinical trials and patients referred to outpatient palliative care clinics. J Pain Symptom Manage 2012 0.79
209 Growth of an academic palliative medicine program: patient encounters and clinical burden. J Pain Symptom Manage 2012 0.78
210 Opioids masquerading as delirium in a patient with cancer pain and obstructive sleep apnea. J Palliat Med 2008 0.78
211 Objective evaluation of physical function in patients with advanced lung cancer: a preliminary report. J Palliat Med 2006 0.78
212 The epidemiology of long- and short-term cancer survivors. A population-based cohort study exploring denominators for rehabilitation and palliative care programs. Acta Oncol 2013 0.78
213 Transdermal fentanyl: not ready for front line. J Palliat Care 2009 0.78
214 Comprehensive approaches to managing delirium in patients with advanced cancer. Cancer Treat Rev 2012 0.78
215 Development and cross-validation of the in-hospital mortality prediction in advanced cancer patients score: a preliminary study. J Palliat Med 2012 0.78
216 Access to opioid analgesics and pain relief for patients with cancer. Nat Rev Clin Oncol 2013 0.78
217 A randomized double-blind crossover comparison of continuous and intermittent subcutaneous administration of opioid for cancer pain. J Palliat Med 2008 0.78
218 Frequency and reasons for return to acute care in patients with leukemia undergoing inpatient rehabilitation: a preliminary report. Am J Phys Med Rehabil 2013 0.78
219 The Evolving Approach to Management of Cancer Cachexia. Oncology (Williston Park) 2017 0.78
220 Food or medicine: ethnic variations in perceptions of advanced cancer patients and their caregivers regarding artificial hydration during the last weeks of life. BMJ Support Palliat Care 2012 0.77
221 High-dose corticosteroids for the management of dyspnea in patients with tumor obstruction of the upper airway. Support Care Cancer 2007 0.77
222 Comparison of postoperative rehabilitation in cancer patients undergoing internal and external hemipelvectomy. Arch Phys Med Rehabil 2011 0.77
223 Management of pain in the older person with cancer. Part 2: treatment options. Oncology (Williston Park) 2008 0.77
224 State of art of managing pain in patients with cancer. Cancer J 2013 0.77
225 Can patient reported outcomes help identify the optimal outcome in palliative surgery? J Surg Oncol 2013 0.77
226 Racial disparities in length of stay in hospice care by tumor stage in a large elderly cohort with non-small cell lung cancer. Palliat Med 2011 0.77
227 Palliative sedation: when the family and consulting service see no alternative. J Palliat Med 2007 0.77
228 Process and content of decision making by advanced cancer patients. J Clin Oncol 2006 0.77
229 Outcome measures other than morbidity and mortality for patients with incurable cancer and gastrointestinal obstruction. J Palliat Med 2013 0.77
230 Pain and terminal delirium research in the elderly. Clin Geriatr Med 2005 0.77
231 Palliative care. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2006 0.76
232 Review of clinical trials of pharmacologic interventions for cancer-related fatigue: focus on psychostimulants and steroids. Cancer J 2014 0.76
233 Update on combined modalities for the management of breathlessness. Curr Opin Support Palliat Care 2012 0.76
234 Cancer patients' perception of the quality of communication before and after the implementation of a communication strategy in a regional cancer center in India. J Clin Oncol 2005 0.76
235 Assessment and management of pain in the terminally ill. Prim Care 2011 0.76
236 Inpatient cancer rehabilitation: the experience of a national comprehensive cancer center. Am J Phys Med Rehabil 2011 0.76
237 Early integration of palliative and supportive care in the cancer continuum: challenges and opportunities. Am Soc Clin Oncol Educ Book 2013 0.76
238 Evaluating Disability Insurance Assistance as a Specific Intervention by Physiatrists at a Cancer Center. Am J Phys Med Rehabil 2016 0.76
239 Azotemia in cancer patients during inpatient rehabilitation. Am J Hosp Palliat Care 2007 0.76
240 Studying the effectiveness of palliative care. JAMA 2008 0.76
241 Subcutaneous administration of cefepime. J Pain Symptom Manage 2005 0.76
242 Methadone rotation for cancer patients with refractory pain in a palliative care unit: an observational study. J Palliat Med 2013 0.76
243 Hypocalcemia associated with strontium-89 administration in a patient with diffuse bone metastases from neuroendocrine carcinoma. J Pain Symptom Manage 2008 0.75
244 Extreme hypothyroidism associated with sunitinib treatment for metastatic renal cancer. J Chemother 2012 0.75
245 The burden of fatigue in cancer patients. Onkologie 2009 0.75
246 A multicenter survey of Hispanic caregiver preferences for patient decision control in the United States and Latin America. Palliat Med 2013 0.75
247 The last days of life: symptom burden and impact on nutrition and hydration in cancer patients. Curr Opin Support Palliat Care 2015 0.75
248 Predictors of anticoagulation in hospice patients with lung cancer. Cancer 2010 0.75
249 Re: Use of IM narcotic injections in hospitalized patients. J Pain Symptom Manage 2003 0.75
250 Reply to H. Yamane et al and M. Franco et al. J Clin Oncol 2014 0.75
251 Palliative care and physician responsibility. J Palliat Med 2006 0.75
252 "Whatever my mother wants": barriers to adequate pain management. J Palliat Med 2012 0.75
253 Attitudes and perceptions of patients, caregivers, and health care providers toward background music in patient care areas: an exploratory study. J Palliat Med 2012 0.75
254 Cancer pain--progress and ongoing issues in the United States. Pain Res Manag 2009 0.75
255 Post-Discharge Survival Outcomes of Patients with Advanced Cancer from the University of Texas MD Anderson Cancer Center Investigational Cancer Therapeutics (Phase I Trials) Inpatient Unit. Oncology 2016 0.75
256 Approach to the older patient with cancer. BMC Med 2013 0.75
257 Very-low-dose methadone: authors' response. J Palliat Med 2013 0.75
258 Cannabinoids in supportive care: are they necessary? Support Care Cancer 2003 0.75
259 Dying patients and palliative sedation. JAMA 2006 0.75
260 Use of injectable spasticity management agents in a cancer center. Support Care Cancer 2012 0.75
261 Palliative care unit and medical intensive care unit deaths. Palliat Support Care 2013 0.75
262 Palliative care unit and medical intensive care unit deaths. Palliat Support Care 2012 0.75
263 Cancer-related fatigue, the role of adrenal suppression and steroids: reply to the comments of Eren et al. Support Care Cancer 2014 0.75
264 Personalizing treatment decisions for cancer patients at the end of life: reply to Soh and Wong. J Pain Symptom Manage 2013 0.75
265 Discussing goals of care for a delirious advanced cancer patient in the hospice setting. J Palliat Med 2013 0.75
266 Neuroleptics in the management of delirium in patients with advanced cancer. Curr Opin Support Palliat Care 2016 0.75
267 Acute palliative care units: an essential component of the science of caring. Cancer J 2014 0.75
268 The influence of hyperglycemia and other clinical variables on rehabilitation and hospital length of stay after neurosurgery in patients with cancer. Am J Hosp Palliat Care 2010 0.75
269 Assessing patient care in palliative care using the healthcare matrix. J Palliat Med 2013 0.75
270 Poster 306 Rehabilitation of Patients Undergoing Sacrectomies: A Case Report. PM R 2016 0.75
271 E-motions: email for written emotional expression. J Clin Oncol 2003 0.75
272 When and when not to use testosterone for palliation in cancer care. Curr Oncol Rep 2014 0.75
273 Recent developments in cancer pain assessment and management. Support Cancer Ther 2004 0.75
274 Maladaptive medical coping: a means to avoid end-of-life discussions. J Palliat Care 2014 0.75
275 International Association for Hospice and Palliative Care (IAHPC): working to improve access to palliative care. Palliat Med 2004 0.75
276 Nutritional status of cancer patients and its relationship to function in an inpatient rehabilitation setting. Support Care Cancer 2004 0.75
277 Use of short-acting opioids in the management of breathlessness: an evidence-based review. Curr Opin Support Palliat Care 2020 0.75
278 Possible exacerbation of adrenal suppression from intrathecal morphine in a patient receiving pulsed dexamethasone for multiple myeloma. J Pain Symptom Manage 2003 0.75
279 Managing high dose sufentanil in a suffering patient. J Pain Symptom Manage 2008 0.75
280 Use of a prone transfer technique in patients with severe hip-flexion restrictions: a report of 3 cases. Arch Phys Med Rehabil 2003 0.75
281 Patient evaluation and delivery of care at the bedside: increasing well-being. J Palliat Care 2014 0.75
282 Evaluating Disability Insurance Assistance as a Specific Intervention by Physiatrists at a Cancer Center. Am J Phys Med Rehabil 2017 0.75
283 Intractable pain: intoxication or undermedication? J Palliat Med 2007 0.75
284 Characteristics and outcomes of advanced cancer patients who miss outpatient supportive care consult appointments. Support Care Cancer 2014 0.75
285 Heterotopic ossification in critical illness and cancer: a report of 2 cases. Arch Phys Med Rehabil 2002 0.75
286 Patient-controlled analgesia in patients with advanced cancer. Should patients be in control? J Pain Symptom Manage 2011 0.75
287 Whose responsibility? J Palliat Care 2003 0.75
288 Use of trade names of drugs and the scientific content of medical congresses. J Clin Oncol 2002 0.75
289 Regional palliative care program in Extremadura: an effective public health care model in a sparsely populated region. J Pain Symptom Manage 2007 0.75
290 Childhood sexual abuse in advanced cancer patients in the palliative care setting. J Pain Symptom Manage 2011 0.75
291 Psychosocial assessment of patients who have undergone inpatient cancer rehabilitation. Am J Hosp Palliat Care 2007 0.75
292 E-motions: email for written emotional expression. J Clin Oncol 2002 0.75
293 Till death do us part: getting married at the end of life. J Pain Symptom Manage 2012 0.75
294 Methadone: an orphan drug? J Palliat Med 2004 0.75
295 Progress in genomic technology: a new challenge for the palliative medicine? J Pain Symptom Manage 2010 0.75
296 Strategic pain management: the identification and development of the IAHPC opioid essential prescription package. J Palliat Med 2011 0.75
297 Frequency of venous thromboembolism events during acute inpatient rehabilitation in a comprehensive cancer centre. J Rehabil Med 2017 0.75
298 Changes in medication profile among patients with advanced cancer admitted to an acute palliative care unit. Support Care Cancer 2014 0.75
299 Cordotomy for treatment of cancer-related pain: patient selection and intervention timing. Neurosurg Focus 2013 0.75
300 Improving the care of terminally ill cancer patients and their families. J Clin Oncol 2005 0.75
301 Use of intravenous fentanyl against morphine tolerance in breakthrough cancer pain: a case series and literature review. Am J Hosp Palliat Care 2013 0.75
302 "Early palliative care: how?" From a conference report to a consensus document, Bentivoglio, May 14, 2012. J Palliat Med 2013 0.75
303 [Information disclosure and decision making preferences of patients with advanced cancer in a Pain and Palliative Care Unit in Chile]. Rev Med Chil 2014 0.75
304 Communication in cancer care: recent developments. J Palliat Care 2002 0.75